nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—ankylosing spondylitis	0.744	1	CpDpCtD
Almotriptan—CYP2C19—Prednisone—ankylosing spondylitis	0.0226	0.142	CbGbCtD
Almotriptan—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0225	0.141	CbGbCtD
Almotriptan—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0181	0.113	CbGbCtD
Almotriptan—HTR1B—dura mater—ankylosing spondylitis	0.0172	0.494	CbGeAlD
Almotriptan—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0168	0.105	CbGbCtD
Almotriptan—HTR1D—dura mater—ankylosing spondylitis	0.0166	0.478	CbGeAlD
Almotriptan—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0141	0.0884	CbGbCtD
Almotriptan—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0137	0.0857	CbGbCtD
Almotriptan—CYP3A4—Betamethasone—ankylosing spondylitis	0.0117	0.0735	CbGbCtD
Almotriptan—CYP3A4—Prednisolone—ankylosing spondylitis	0.0116	0.0725	CbGbCtD
Almotriptan—CYP3A4—Prednisone—ankylosing spondylitis	0.0109	0.0685	CbGbCtD
Almotriptan—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0107	0.0672	CbGbCtD
Almotriptan—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00683	0.0428	CbGbCtD
Almotriptan—MAOA—tendon—ankylosing spondylitis	0.00055	0.0158	CbGeAlD
Almotriptan—CYP2E1—tendon—ankylosing spondylitis	0.000413	0.0119	CbGeAlD
Almotriptan—Erythema—Betamethasone—ankylosing spondylitis	0.00018	0.00294	CcSEcCtD
Almotriptan—Malaise—Triamcinolone—ankylosing spondylitis	0.000179	0.00292	CcSEcCtD
Almotriptan—Malaise—Methylprednisolone—ankylosing spondylitis	0.000178	0.00291	CcSEcCtD
Almotriptan—Vertigo—Triamcinolone—ankylosing spondylitis	0.000178	0.00291	CcSEcCtD
Almotriptan—Syncope—Triamcinolone—ankylosing spondylitis	0.000178	0.0029	CcSEcCtD
Almotriptan—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000178	0.0029	CcSEcCtD
Almotriptan—Syncope—Methylprednisolone—ankylosing spondylitis	0.000177	0.00289	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000176	0.00287	CcSEcCtD
Almotriptan—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000174	0.00284	CcSEcCtD
Almotriptan—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000174	0.00284	CcSEcCtD
Almotriptan—Shock—Prednisolone—ankylosing spondylitis	0.000173	0.00282	CcSEcCtD
Almotriptan—Convulsion—Triamcinolone—ankylosing spondylitis	0.000172	0.0028	CcSEcCtD
Almotriptan—Tachycardia—Prednisolone—ankylosing spondylitis	0.000172	0.0028	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000171	0.0028	CcSEcCtD
Almotriptan—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000171	0.0028	CcSEcCtD
Almotriptan—Hypertension—Triamcinolone—ankylosing spondylitis	0.000171	0.00279	CcSEcCtD
Almotriptan—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000171	0.00279	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00017	0.00278	CcSEcCtD
Almotriptan—Myalgia—Triamcinolone—ankylosing spondylitis	0.000169	0.00275	CcSEcCtD
Almotriptan—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000168	0.00275	CcSEcCtD
Almotriptan—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000168	0.00275	CcSEcCtD
Almotriptan—Eye disorder—Prednisone—ankylosing spondylitis	0.000168	0.00274	CcSEcCtD
Almotriptan—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000168	0.00274	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000167	0.00273	CcSEcCtD
Almotriptan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000167	0.00272	CcSEcCtD
Almotriptan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000167	0.00272	CcSEcCtD
Almotriptan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000167	0.00272	CcSEcCtD
Almotriptan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000166	0.00272	CcSEcCtD
Almotriptan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000165	0.00269	CcSEcCtD
Almotriptan—Angioedema—Betamethasone—ankylosing spondylitis	0.000164	0.00268	CcSEcCtD
Almotriptan—Angioedema—Dexamethasone—ankylosing spondylitis	0.000164	0.00268	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000163	0.00266	CcSEcCtD
Almotriptan—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000163	0.00266	CcSEcCtD
Almotriptan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000162	0.00265	CcSEcCtD
Almotriptan—Malaise—Dexamethasone—ankylosing spondylitis	0.000162	0.00265	CcSEcCtD
Almotriptan—Malaise—Betamethasone—ankylosing spondylitis	0.000162	0.00265	CcSEcCtD
Almotriptan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000162	0.00264	CcSEcCtD
Almotriptan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000162	0.00264	CcSEcCtD
Almotriptan—Vertigo—Betamethasone—ankylosing spondylitis	0.000162	0.00264	CcSEcCtD
Almotriptan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000161	0.00263	CcSEcCtD
Almotriptan—Syncope—Dexamethasone—ankylosing spondylitis	0.000161	0.00263	CcSEcCtD
Almotriptan—Syncope—Betamethasone—ankylosing spondylitis	0.000161	0.00263	CcSEcCtD
Almotriptan—Shock—Triamcinolone—ankylosing spondylitis	0.000159	0.0026	CcSEcCtD
Almotriptan—Insomnia—Prednisolone—ankylosing spondylitis	0.000159	0.0026	CcSEcCtD
Almotriptan—Shock—Methylprednisolone—ankylosing spondylitis	0.000159	0.00259	CcSEcCtD
Almotriptan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000158	0.00258	CcSEcCtD
Almotriptan—Mental disorder—Prednisone—ankylosing spondylitis	0.000158	0.00257	CcSEcCtD
Almotriptan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000157	0.00257	CcSEcCtD
Almotriptan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000157	0.00256	CcSEcCtD
Almotriptan—Erythema—Prednisone—ankylosing spondylitis	0.000157	0.00256	CcSEcCtD
Almotriptan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000156	0.00255	CcSEcCtD
Almotriptan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000156	0.00255	CcSEcCtD
Almotriptan—Convulsion—Betamethasone—ankylosing spondylitis	0.000156	0.00254	CcSEcCtD
Almotriptan—Convulsion—Dexamethasone—ankylosing spondylitis	0.000156	0.00254	CcSEcCtD
Almotriptan—Hypertension—Dexamethasone—ankylosing spondylitis	0.000155	0.00253	CcSEcCtD
Almotriptan—Hypertension—Betamethasone—ankylosing spondylitis	0.000155	0.00253	CcSEcCtD
Almotriptan—Myalgia—Dexamethasone—ankylosing spondylitis	0.000153	0.0025	CcSEcCtD
Almotriptan—Myalgia—Betamethasone—ankylosing spondylitis	0.000153	0.0025	CcSEcCtD
Almotriptan—Anxiety—Dexamethasone—ankylosing spondylitis	0.000153	0.00249	CcSEcCtD
Almotriptan—Anxiety—Betamethasone—ankylosing spondylitis	0.000153	0.00249	CcSEcCtD
Almotriptan—Discomfort—Betamethasone—ankylosing spondylitis	0.000151	0.00247	CcSEcCtD
Almotriptan—Discomfort—Dexamethasone—ankylosing spondylitis	0.000151	0.00247	CcSEcCtD
Almotriptan—Pain—Prednisolone—ankylosing spondylitis	0.00015	0.00246	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000149	0.00244	CcSEcCtD
Almotriptan—Vision blurred—Prednisone—ankylosing spondylitis	0.000148	0.00241	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000147	0.00241	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000147	0.0024	CcSEcCtD
Almotriptan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000147	0.0024	CcSEcCtD
Almotriptan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000147	0.0024	CcSEcCtD
Almotriptan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000146	0.00239	CcSEcCtD
Almotriptan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000146	0.00238	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000145	0.00237	CcSEcCtD
Almotriptan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000145	0.00237	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000145	0.00237	CcSEcCtD
Almotriptan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000145	0.00237	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—ankylosing spondylitis	0.000145	0.00237	CcSEcCtD
Almotriptan—Shock—Dexamethasone—ankylosing spondylitis	0.000144	0.00236	CcSEcCtD
Almotriptan—Shock—Betamethasone—ankylosing spondylitis	0.000144	0.00236	CcSEcCtD
Almotriptan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000144	0.00235	CcSEcCtD
Almotriptan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000144	0.00235	CcSEcCtD
Almotriptan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000144	0.00235	CcSEcCtD
Almotriptan—Agitation—Prednisone—ankylosing spondylitis	0.000144	0.00235	CcSEcCtD
Almotriptan—Tachycardia—Betamethasone—ankylosing spondylitis	0.000143	0.00234	CcSEcCtD
Almotriptan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000143	0.00234	CcSEcCtD
Almotriptan—Angioedema—Prednisone—ankylosing spondylitis	0.000143	0.00234	CcSEcCtD
Almotriptan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000142	0.00232	CcSEcCtD
Almotriptan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000142	0.00232	CcSEcCtD
Almotriptan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000142	0.00232	CcSEcCtD
Almotriptan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000142	0.00232	CcSEcCtD
Almotriptan—Malaise—Prednisone—ankylosing spondylitis	0.000141	0.00231	CcSEcCtD
Almotriptan—Vertigo—Prednisone—ankylosing spondylitis	0.000141	0.0023	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—ankylosing spondylitis	0.00014	0.00229	CcSEcCtD
Almotriptan—Syncope—Prednisone—ankylosing spondylitis	0.00014	0.00229	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—ankylosing spondylitis	0.00014	0.00229	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00014	0.00228	CcSEcCtD
Almotriptan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000139	0.00228	CcSEcCtD
Almotriptan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000139	0.00227	CcSEcCtD
Almotriptan—Pain—Triamcinolone—ankylosing spondylitis	0.000138	0.00226	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000138	0.00225	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000136	0.00222	CcSEcCtD
Almotriptan—Convulsion—Prednisone—ankylosing spondylitis	0.000136	0.00221	CcSEcCtD
Almotriptan—Hypertension—Prednisone—ankylosing spondylitis	0.000135	0.00221	CcSEcCtD
Almotriptan—Chills—Methotrexate—ankylosing spondylitis	0.000135	0.0022	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000134	0.00218	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000134	0.00218	CcSEcCtD
Almotriptan—Myalgia—Prednisone—ankylosing spondylitis	0.000133	0.00218	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—ankylosing spondylitis	0.000133	0.00218	CcSEcCtD
Almotriptan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000133	0.00218	CcSEcCtD
Almotriptan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000133	0.00217	CcSEcCtD
Almotriptan—Anxiety—Prednisone—ankylosing spondylitis	0.000133	0.00217	CcSEcCtD
Almotriptan—Insomnia—Dexamethasone—ankylosing spondylitis	0.000133	0.00217	CcSEcCtD
Almotriptan—Insomnia—Betamethasone—ankylosing spondylitis	0.000133	0.00217	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000132	0.00216	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000132	0.00215	CcSEcCtD
Almotriptan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000132	0.00215	CcSEcCtD
Almotriptan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000132	0.00215	CcSEcCtD
Almotriptan—Discomfort—Prednisone—ankylosing spondylitis	0.000132	0.00215	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—ankylosing spondylitis	0.000132	0.00215	CcSEcCtD
Almotriptan—Erythema—Methotrexate—ankylosing spondylitis	0.000131	0.00214	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00013	0.00212	CcSEcCtD
Almotriptan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000129	0.00211	CcSEcCtD
Almotriptan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000129	0.00211	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000128	0.00209	CcSEcCtD
Almotriptan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000128	0.00209	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000128	0.00209	CcSEcCtD
Almotriptan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000128	0.00208	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000127	0.00207	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000127	0.00207	CcSEcCtD
Almotriptan—Back pain—Methotrexate—ankylosing spondylitis	0.000127	0.00207	CcSEcCtD
Almotriptan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000127	0.00207	CcSEcCtD
Almotriptan—Fatigue—Betamethasone—ankylosing spondylitis	0.000127	0.00207	CcSEcCtD
Almotriptan—Shock—Prednisone—ankylosing spondylitis	0.000126	0.00205	CcSEcCtD
Almotriptan—Pain—Dexamethasone—ankylosing spondylitis	0.000125	0.00205	CcSEcCtD
Almotriptan—Pain—Betamethasone—ankylosing spondylitis	0.000125	0.00205	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000125	0.00205	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—ankylosing spondylitis	0.000125	0.00204	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—ankylosing spondylitis	0.000124	0.00203	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000124	0.00202	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—ankylosing spondylitis	0.000123	0.00201	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000121	0.00198	CcSEcCtD
Almotriptan—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000121	0.00197	CcSEcCtD
Almotriptan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000121	0.00197	CcSEcCtD
Almotriptan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00012	0.00196	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00012	0.00196	CcSEcCtD
Almotriptan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000119	0.00195	CcSEcCtD
Almotriptan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000119	0.00194	CcSEcCtD
Almotriptan—Malaise—Methotrexate—ankylosing spondylitis	0.000118	0.00193	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—ankylosing spondylitis	0.000118	0.00192	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000116	0.0019	CcSEcCtD
Almotriptan—Dizziness—Prednisolone—ankylosing spondylitis	0.000116	0.0019	CcSEcCtD
Almotriptan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Insomnia—Prednisone—ankylosing spondylitis	0.000116	0.00189	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—ankylosing spondylitis	0.000115	0.00187	CcSEcCtD
Almotriptan—Pruritus—Triamcinolone—ankylosing spondylitis	0.000114	0.00187	CcSEcCtD
Almotriptan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000114	0.00186	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—ankylosing spondylitis	0.000113	0.00185	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000112	0.00184	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—ankylosing spondylitis	0.000111	0.00182	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—ankylosing spondylitis	0.000111	0.00182	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—ankylosing spondylitis	0.000111	0.00182	CcSEcCtD
Almotriptan—Rash—Prednisolone—ankylosing spondylitis	0.000111	0.00181	CcSEcCtD
Almotriptan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000111	0.00181	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000111	0.00181	CcSEcCtD
Almotriptan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00011	0.0018	CcSEcCtD
Almotriptan—Fatigue—Prednisone—ankylosing spondylitis	0.00011	0.0018	CcSEcCtD
Almotriptan—Headache—Prednisolone—ankylosing spondylitis	0.00011	0.0018	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—ankylosing spondylitis	0.00011	0.0018	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—ankylosing spondylitis	0.000108	0.00176	CcSEcCtD
Almotriptan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000107	0.00175	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000107	0.00174	CcSEcCtD
Almotriptan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000107	0.00174	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000105	0.00172	CcSEcCtD
Almotriptan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000105	0.00172	CcSEcCtD
Almotriptan—Asthenia—Betamethasone—ankylosing spondylitis	0.000105	0.00172	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000105	0.00171	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000104	0.00171	CcSEcCtD
Almotriptan—Nausea—Prednisolone—ankylosing spondylitis	0.000104	0.00171	CcSEcCtD
Almotriptan—Pruritus—Betamethasone—ankylosing spondylitis	0.000104	0.00169	CcSEcCtD
Almotriptan—Pruritus—Dexamethasone—ankylosing spondylitis	0.000104	0.00169	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—ankylosing spondylitis	0.000104	0.00169	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000103	0.00169	CcSEcCtD
Almotriptan—Vomiting—Triamcinolone—ankylosing spondylitis	0.000103	0.00168	CcSEcCtD
Almotriptan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000103	0.00168	CcSEcCtD
Almotriptan—Rash—Triamcinolone—ankylosing spondylitis	0.000102	0.00166	CcSEcCtD
Almotriptan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000102	0.00166	CcSEcCtD
Almotriptan—Rash—Methylprednisolone—ankylosing spondylitis	0.000102	0.00166	CcSEcCtD
Almotriptan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000102	0.00166	CcSEcCtD
Almotriptan—Headache—Triamcinolone—ankylosing spondylitis	0.000101	0.00165	CcSEcCtD
Almotriptan—Headache—Methylprednisolone—ankylosing spondylitis	0.000101	0.00165	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000101	0.00165	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—ankylosing spondylitis	0.000101	0.00165	CcSEcCtD
Almotriptan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.0001	0.00164	CcSEcCtD
Almotriptan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.0001	0.00164	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	9.73e-05	0.00159	CcSEcCtD
Almotriptan—Dizziness—Dexamethasone—ankylosing spondylitis	9.7e-05	0.00158	CcSEcCtD
Almotriptan—Dizziness—Betamethasone—ankylosing spondylitis	9.7e-05	0.00158	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—ankylosing spondylitis	9.66e-05	0.00158	CcSEcCtD
Almotriptan—Nausea—Triamcinolone—ankylosing spondylitis	9.61e-05	0.00157	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—ankylosing spondylitis	9.59e-05	0.00157	CcSEcCtD
Almotriptan—Nausea—Methylprednisolone—ankylosing spondylitis	9.58e-05	0.00156	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—ankylosing spondylitis	9.52e-05	0.00155	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—ankylosing spondylitis	9.49e-05	0.00155	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—ankylosing spondylitis	9.41e-05	0.00154	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—ankylosing spondylitis	9.4e-05	0.00153	CcSEcCtD
Almotriptan—Vomiting—Dexamethasone—ankylosing spondylitis	9.33e-05	0.00152	CcSEcCtD
Almotriptan—Vomiting—Betamethasone—ankylosing spondylitis	9.33e-05	0.00152	CcSEcCtD
Almotriptan—Rash—Dexamethasone—ankylosing spondylitis	9.25e-05	0.00151	CcSEcCtD
Almotriptan—Rash—Betamethasone—ankylosing spondylitis	9.25e-05	0.00151	CcSEcCtD
Almotriptan—Dermatitis—Dexamethasone—ankylosing spondylitis	9.24e-05	0.00151	CcSEcCtD
Almotriptan—Dermatitis—Betamethasone—ankylosing spondylitis	9.24e-05	0.00151	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	9.22e-05	0.00151	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—ankylosing spondylitis	9.21e-05	0.0015	CcSEcCtD
Almotriptan—Headache—Dexamethasone—ankylosing spondylitis	9.19e-05	0.0015	CcSEcCtD
Almotriptan—Headache—Betamethasone—ankylosing spondylitis	9.19e-05	0.0015	CcSEcCtD
Almotriptan—Asthenia—Prednisone—ankylosing spondylitis	9.17e-05	0.0015	CcSEcCtD
Almotriptan—Pain—Methotrexate—ankylosing spondylitis	9.13e-05	0.00149	CcSEcCtD
Almotriptan—Pruritus—Prednisone—ankylosing spondylitis	9.04e-05	0.00148	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—ankylosing spondylitis	8.8e-05	0.00144	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—ankylosing spondylitis	8.74e-05	0.00143	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.73e-05	0.00143	CcSEcCtD
Almotriptan—Nausea—Dexamethasone—ankylosing spondylitis	8.72e-05	0.00142	CcSEcCtD
Almotriptan—Nausea—Betamethasone—ankylosing spondylitis	8.72e-05	0.00142	CcSEcCtD
Almotriptan—Dizziness—Prednisone—ankylosing spondylitis	8.45e-05	0.00138	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—ankylosing spondylitis	8.44e-05	0.00138	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—ankylosing spondylitis	8.44e-05	0.00138	CcSEcCtD
Almotriptan—Vomiting—Prednisone—ankylosing spondylitis	8.12e-05	0.00133	CcSEcCtD
Almotriptan—Rash—Prednisone—ankylosing spondylitis	8.06e-05	0.00132	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—ankylosing spondylitis	8.05e-05	0.00131	CcSEcCtD
Almotriptan—Headache—Prednisone—ankylosing spondylitis	8.01e-05	0.00131	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.87e-05	0.00128	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—ankylosing spondylitis	7.66e-05	0.00125	CcSEcCtD
Almotriptan—Nausea—Prednisone—ankylosing spondylitis	7.59e-05	0.00124	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—ankylosing spondylitis	7.56e-05	0.00123	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—ankylosing spondylitis	7.31e-05	0.00119	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—ankylosing spondylitis	7.06e-05	0.00115	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—ankylosing spondylitis	6.79e-05	0.00111	CcSEcCtD
Almotriptan—Rash—Methotrexate—ankylosing spondylitis	6.73e-05	0.0011	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—ankylosing spondylitis	6.73e-05	0.0011	CcSEcCtD
Almotriptan—Headache—Methotrexate—ankylosing spondylitis	6.69e-05	0.00109	CcSEcCtD
Almotriptan—Nausea—Methotrexate—ankylosing spondylitis	6.34e-05	0.00104	CcSEcCtD
